Antimicrobial And Antithrombotic Articles With Adhesion-Reducing Copolymers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing artificial materials suffer from adhesion of proteins, blood components, cells, or bacteria, leading to poor performance and harmful biological reactions.

Innovation Solution

A copolymer containing a vinyl alcohol unit and a vinyl monomer unit with a side chain, with a specific molar ratio, is used to reduce adhesion, exhibiting low protein, cell, and bacterial adhesion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If conventional artificial materials are used, then manufacturing is simple and cost-effective, but adhesion of proteins, blood components, cells, or bacteria occurs leading to poor performance and harmful biological reactions

Engineering Contradiction:
Improveadhesion of proteins, blood components, cells, or bacteriaVSAvoidcopolymer composition complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent applies composite materials by creating a copolymer that combines vinyl alcohol units with vinyl monomer units containing specific side chains (carboxyl, hydroxyl, or amino groups). This composite polymer structure integrates multiple functional groups within a single material system, achieving reduced adhesion of proteins, blood components, cells, and bacteria while maintaining manufacturability. The specific molar ratio range (60/40)-(90/10) optimizes the balance between adhesion prevention and material properties.

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If fluorine-containing polymer coating is applied to prevent protein adsorption, then protein adhesion is reduced, but the material lacks broad-spectrum effectiveness against cells and bacteria

Engineering Contradiction:
Improveprotein adsorption preventionVSAvoideffectiveness against multiple biological components
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The patent applies local quality by incorporating different functional side chains (carboxyl, hydroxyl, and amino groups) at specific positions within the polymer structure. Each functional group provides localized chemical properties that interact differently with various biological components. The vinyl monomer units with these side chains are distributed throughout the polymer chain at controlled ratios, creating local regions with specific adhesion-preventing properties that collectively provide broad-spectrum effectiveness against proteins, blood components, cells, and bacteria.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent achieves universality by designing a copolymer structure where vinyl alcohol units combined with vinyl monomer units containing carboxyl, hydroxyl, or amino side chains provide multiple functions in a single material. This multi-functional copolymer simultaneously prevents adhesion of proteins, blood components, cells, and bacteria, making it universally applicable across different biomedical applications without requiring separate specialized coatings for each biological threat.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Object-affected harmful factors

If temperature responsive polymer is used to prevent adhesion of blood components, then antithrombotic performance is achieved, but the material does not provide antimicrobial or cell culture functionality

Engineering Contradiction:
Improveadhesion of blood componentsVSAvoidantimicrobial and cell culture performance
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The patent achieves universality by designing a copolymer structure where vinyl alcohol units combined with vinyl monomer units containing carboxyl, hydroxyl, or amino side chains provide multiple functions in a single material. This multi-functional copolymer simultaneously prevents adhesion of proteins, blood components, cells, and bacteria, making it universally applicable across different biomedical applications without requiring separate specialized coatings for each biological threat.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentEP3650054B1Antimicrobial, antithrombotic, cell culture or biopharmaceutical articles
Publication Date: 2025.10.29 DAIKIN INDUSTRIES LTD
  • EP3650054B1 patent drawing
  • EP3650054B1 patent drawing
  • EP3650054B1 patent drawing

AI summary

The invention provides an antimicrobial article, a cell culture article, an antithrombotic article, or a biopharmaceutical article that can reduce adhesion of proteins, blood components, cells, or bacteria. The antimicrobial article, the cell culture article, the antithrombotic article, or the biopharmaceutical article contains a copolymer that contains a polymerized unit (A) represented by -CH2-CHOH- and a polymerized unit (B) represented by -CH2-CX2-, wherein Xs are the same as or different from each other, and are each an alkyl group having a carbon number of 1 or greater, having a linear, branched, or cyclic structure, and optionally containing an oxygen atom between carbon atoms, an alkoxy group having a carbon number of 1 or greater, having a linear, branched, or cyclic structure, and optionally containing a hetero atom between carbon atoms, a siloxy group having a carbon number of 3 or greater, an ester group containing an aromatic ring or an alkyl group having a carbon number of 1 or greater and having a linear, branched, or cyclic structure, or H, excluding those in which both Xs are H.